bladder urothelial carcinoma
Original Article Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells
8
Case Report Testicular metastasis of bladder urothelial carcinoma: a case report and related factors
6
Original Article Fascin expression in urinary bladder urothelial carcinoma correlates with unfavourable prognosis
7
Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma
19
Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
10
DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma
8
Case Report Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma
7
Integrative omics analyses broaden treatment targets in human cancer
20
<p>Assessment of tumor mutation burden calculation from gene panel sequencing data</p>
9
Original Article High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder
11
DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
14
Case Report Inverted variant of urothelial carcinoma of the urinary bladder: a report of three cases and a proposal for a new clinicopathologic entity
5
Original Article Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence
9
New therapeutic targets in the management of urothelial carcinoma of the bladder
13
Isolated cardiac metastasis from plasmacytoid urothelial carcinoma of the bladder
5
Recurrence and upstaging rates of T1 high grade urothelial carcinoma of the bladder on repeat resection in a Canadian, resource limited, healthcare system
8
Sex-related differences in urothelial cell carcinoma of the bladder in Germany
8
A phase I/II trial of fixed dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
9
Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
9
Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis
14